Liquidia Corp. (LQDA)
55.19
+3.79
(+7.37%)
USD |
NASDAQ |
Nov 11, 16:00
54.30
-0.89
(-1.61%)
After-Hours: 20:00
Liquidia Price : 55.19 for Nov. 11, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 10, 2026 | 48.73 | 51.69 | 46.21 | 51.40 | 2.849M |
| Nov 09, 2026 | 45.70 | 48.24 | 45.08 | 47.87 | 2.161M |
| Nov 06, 2026 | 44.60 | 45.69 | 44.23 | 44.40 | 1.472M |
| Nov 05, 2026 | 47.38 | 47.46 | 44.39 | 44.49 | 2.142M |
| Nov 04, 2026 | 43.32 | 51.11 | 43.24 | 47.38 | 4.816M |
| Nov 03, 2026 | 41.69 | 43.37 | 41.52 | 42.20 | 2.182M |
| Nov 02, 2026 | 45.71 | 45.71 | 41.65 | 41.85 | 2.588M |
| Oct 30, 2026 | 44.56 | 46.29 | 44.24 | 45.06 | 2.092M |
| Oct 29, 2026 | 46.23 | 47.20 | 44.41 | 44.99 | 2.639M |
| Oct 28, 2026 | 45.42 | 47.18 | 45.00 | 45.72 | 2.265M |
| Oct 27, 2026 | 43.88 | 46.36 | 43.70 | 45.44 | 3.184M |
| Oct 26, 2026 | 42.77 | 45.72 | 42.12 | 43.74 | 4.116M |
| Oct 23, 2026 | 39.86 | 42.83 | 38.69 | 42.65 | 3.806M |
| Oct 22, 2026 | 38.75 | 40.08 | 38.22 | 39.69 | 3.534M |
| Oct 21, 2026 | 36.65 | 39.20 | 36.51 | 38.86 | 3.885M |
| Oct 20, 2026 | 33.90 | 36.93 | 33.65 | 36.35 | 3.997M |
| Oct 19, 2026 | 34.42 | 36.82 | 33.76 | 34.13 | 3.028M |
| Oct 16, 2026 | 34.78 | 34.90 | 33.33 | 34.35 | 4.550M |
| Oct 15, 2026 | 34.93 | 35.80 | 32.20 | 34.78 | 7.225M |
| Oct 14, 2026 | 35.70 | 38.64 | 33.12 | 33.94 | 21.14M |
| Oct 13, 2026 | 27.04 | 27.40 | 26.13 | 26.81 | 7.653M |
| Oct 12, 2026 | 29.27 | 30.86 | 27.28 | 27.67 | 4.414M |
| Oct 09, 2026 | 27.06 | 28.53 | 26.66 | 27.38 | 3.617M |
| Oct 08, 2026 | 26.34 | 29.35 | 26.34 | 28.02 | 5.260M |
| Oct 07, 2026 | 25.55 | 27.33 | 24.59 | 26.68 | 6.988M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| United Therapeutics Corp. | 595.50 |
| Johnson & Johnson | 280.30 |
| Eli Lilly & Co. | 1436.01 |
| Pfizer Inc. | 29.45 |
| Amneal Pharmaceuticals, Inc. | 21.71 |
Price Related Metrics
| PS Ratio | 8.699 |
| Price to Free Cash Flow | 18.58 |
| Earnings Yield | -2.24% |
| Market Cap | 4.917B |
| Operating PE Ratio | 18.46 |
| Normalized PE Ratio | 30.44 |